glp 1 medication south africa GLP-1 Agonists Weight Loss Drugs Market Size & Outlook, 2033 South African Pharma King Wins

Albiglutide and cardiovascular outcomes In 2018, the trial on albiglutide and CV outcomes in patients with T2DM and CV disease (Heart Attack Reduction with Medications Organized as New Therapies Outcomes) was performed on 9463 participants who were followed for a median duration of 1.6 years

You may have heard lip flips are a trending cosmetic treatment and wonder what the buzz is all about

The venture capital signal If you want to understand where food-industry growth is actually happening, follow venture capital

Compounds with a pI above 7, those rich in basic residues, carry a net positive charge only in acidic conditions

Vitamin B-12 is essential for energy production and cognitive function

PT-141 moves through the body as an antagonist to melanocortin receptors